Role of interferons in LPS hypersensitivity.

Area of Science:

• Immunology
• Microbiology
• Infectious Diseases

Background:

• Innate immune responses to Gram-negative bacteria are primarily dictated by lipopolysaccharide (LPS) sensitivity and bacterial load.
• Two known sensitization pathways exist: strong (IFN-gamma-dependent) and moderate (IFN-gamma-independent), with IL-12 and IL-18 involved in IFN-gamma induction.

Purpose of the Study:

• To investigate a novel pathway for Gram-negative bacteria-induced interferon-gamma (IFN-gamma) production in mice.
• To elucidate the roles of interferon-beta (IFN-beta) and interleukin-18 (IL-18) in this alternative IFN-gamma induction pathway.

Main Methods:

• Experimental induction of innate immune responses in mice using Gram-negative bacteria and their components.
• Analysis of cytokine production (IFN-gamma, IFN-beta, IL-12, IL-18) and signaling pathways (STAT4) following bacterial challenge.
• Comparison of responses in LPS-sensitive versus LPS-non-responder mice.

Main Results:

• Gram-negative bacteria induce IFN-gamma via an IFN-beta-dependent pathway that requires IL-18 but is independent of IL-12 signaling.
• This pathway is STAT4-dependent, with STAT4 activation directly linked to IFN-beta; IFN-alpha can substitute for IFN-beta.
• LPS appears to be the sole bacterial component inducing IFN-beta, making this pathway specific to LPS-responder mice.

Conclusions:

• A novel IFN-beta/IL-18-dependent pathway contributes to IFN-gamma induction during Gram-negative bacterial infections.
• This pathway is crucial in LPS-responder mice and is distinct from the established IL-12-mediated pathway.
• The IFN-alpha/beta-dependent pathway likely plays a significant role when IFN-alpha or IFN-beta and IL-18 are co-produced during infection.